Furthermore, future studies on blocking the lymphocyte inflammation or IL-18/IFN-γ signaling to ameliorate the emphysema phenotype in Hhip+/– murine models and examination of expression of IL-18 in human lung tissue are also warranted to pinpoint the therapeutic applications. The gene discussed is IFNG; the disease is pulmonary emphysema.